ICON PLC (ICLR) Actualités

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR

ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON Reports Fourth Quarter and Full Year 2024 Results

Highlights Net business wins in the quarter of $2,413 million; a net book to bill in the quarter of 1.18. Full year net business wins of $9,974...

ICON Public Limited Company Class Action: The Gross Law Firm Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR

ICON Public Limited Company Class Action: The Gross Law Firm Reminds ICON Investors of the Pending Class...

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

Enterprise Ireland grant awarded to ICON to further enhance artificial intelligence capabilities ICON plc, (NASDAQ: ICLR) a world-leading...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON Issues Financial Guidance for Full Year 2025

Highlights Full year 2025 revenue guidance in the range of $8,050 - $8,650 million; midpoint of $8,350 million representing growth of...

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference

  ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO...

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]